Increased risk for anxiety may begin before birth, shaped by infection or stressful events during pregnancy, according to a new preclinical study from researchers at Weill Cornell Medicine. While scientists have long known that maternal difficulty during pregnancy may raise a child’s risk for psychiatric illness, the biological pathways between these prenatal experiences and later mental health have been unclear.
Research at Risk: Rooting out treatment-resistant prostate cancer
October 7, 2025
Advances in prostate cancer early detection and treatment have improved outcomes in men diagnosed with the disease. Yet doctors and scientists have long been vexed by a question: Why do most men whose prostate cancer initially responds to hormonal-blocking therapy later develop a lethal, treatment-resistant form of the disease?
EIPM's 3Q External Newsletter
October 5, 2025
Welcome to third quarterly external newsletter of 2025!
Fischbach-Teschl to lead Engineering Innovations in Medicine initiative
September 25, 2025
Engineering Innovations in Medicine, an initiative launched by Cornell Engineering and Weill Cornell Medicine in 2022 to transform human health through data-driven innovation and interdisciplinary collaboration, will now be led by Claudia Fischbach-Teschl as part of her portfolio as James M. and Marsha McCormick Family Director of the Meinig School of Biomedical Engineering.
September 2025 EIPM Director's Memo
September 5, 2025
Dear Friends & Members of the Englander Institute,
I hope you enjoy reading about our recent departmental accomplishments, including news media coverage of our work, interesting & engaging departmental events, and impressive publications in top-tier journals like Nature Biotechnology.
August 2025 EIPM Director's Monthly Memo
August 6, 2025
August 2025 EIPM Director's Memo
Dear Friends & Members of the Englander Institute,
As I shared in the most recent EIPM Weekly News Roundup newsletter, I've always taken the most pride in the high-quality research our colleagues have published in leading peer-reviewed journals. But July was truly something special, with outstanding papers (below) by dozens of our team members. Congratulations to everyone who contributed to the outstanding work!
Uncovering How a Molecule Responsible for Immune “Brakes” Directs Skin Defenses
August 1, 2025
Weill Cornell Medicine researchers have discovered that PD-1—a molecule best known for putting the brakes on immune cells—also plays a critical role in helping T cells become long-term immune defenders in the skin. Early during infection, PD-1 acts like a steering wheel, guiding T cells to become protective resident memory T cells (TRM) that stay in place. These cells remember invading germs or cancer and quickly mount a response if that enemy reappears.
$1.1 Million Grant Funds Research on Rare Neurodevelopmental Disorder
July 28, 2025
A $1.1 million grant from the parent-caregiver-led Rare Bird Foundation to Weill Cornell Medicine is supporting the launch of a natural history study for a rare neurodevelopmental disorder that causes developmental delays and seizures called MEF2C Haploinsufficiency syndrome (MCHS).
Switch to Experimental Drug after Liquid Biopsy Detection of Breast Cancer Recurrence Improves Outcomes
July 24, 2025
A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new type of treatment, substantially extends the period of tumor control compared to standard care.
EIPM's 2Q External Newsletter
July 9, 2025
EIPM's Second Quarter 2025 External Newsletter
July 09, 2025
Dear Friend of the Englander Institute for Precision Medicine,
Welcome to second quarterly external newsletter of 2025!